|
|
| | Asapiprant Basic information |
| Product Name: | Asapiprant | | Synonyms: | Asapiprant,S-555739;S-555739;S-555739; S 555739; S555739; ASAPIPRANT;932372-01-5;CS-2811;S 555739;S555739;S-555739; S 555739; S555739; ASAPIPRANT;Acetic acid, 2-[5-[4-[[4-(1-methylethoxy)phenyl]sulfonyl]-1-piperazinyl]-2-(2-oxazolyl)phenoxy]- | | CAS: | 932372-01-5 | | MF: | C24H27N3O7S | | MW: | 501.55 | | EINECS: | | | Product Categories: | APIS | | Mol File: | 932372-01-5.mol |  |
| | Asapiprant Chemical Properties |
| Melting point | >218°C (dec.) | | Boiling point | 731.6±70.0 °C(Predicted) | | density | 1.341±0.06 g/cm3(Predicted) | | storage temp. | -20°C Freezer, Under inert atmosphere | | solubility | Chloroform (Slightly), DMSO (Slightly) | | pka | 2.92±0.10(Predicted) | | form | Solid | | color | White to Off-White |
| | Asapiprant Usage And Synthesis |
| Uses | Asapiprant is a DP1 receptor antagonist, used in the treatment of asthma. |
| | Asapiprant Preparation Products And Raw materials |
|